Polymeric Micelles for Sustained Chemotherapeutic Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current polymer-based nanoformulations for delivering chemotherapeutics like cyclopamine (CPA) and paclitaxel face challenges such as burst release profiles and low payload capacity, limiting their effectiveness in treating pancreatic cancer due to the protective desmoplastic stroma and the need for improved drug delivery methods.

Innovation Solution

Development of block copolymers with a polyacrylic acid backbone and PEG sidechains, combined with ε-caprolactone sidechains, forming micelles that encapsulate chemotherapeutic agents, providing controlled release and enhanced payload capacity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If polymer-based nanoformulations are used to deliver chemotherapeutics, then drug delivery to tumors is improved, but burst release profile occurs which reduces treatment effectiveness

Engineering Contradiction:
Improvedrug delivery effectivenessVSAvoidrelease profile duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The polymer formulation is segmented into distinct functional blocks: a hydrophobic block for drug encapsulation and a hydrophilic PEG block for steric stabilization. This segmentation allows the hydrophobic core to provide sustained drug release while the hydrophilic shell prevents premature release, resolving the burst release issue while maintaining effective drug delivery to tumors.

Inventive Principle:
Principle #1Segmentation

2Reliability

If polymer-based nanoformulations are used to deliver chemotherapeutics, then drug delivery is enhanced, but payload capacity is limited

Engineering Contradiction:
Improvedrug delivery enhancementVSAvoiddrug payload capacity
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The polymer structure exhibits local quality differentiation with a hydrophobic core region optimized for high drug payload encapsulation and a hydrophilic PEG shell region optimized for circulation stability. This local quality assignment allows the core to maximize drug loading capacity while the shell provides the necessary stability for enhanced drug delivery, resolving the contradiction between payload capacity and delivery enhancement.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polymer-based micelles achieve sustained release of chemotherapeutic agents, effectively depleting cancer stem cells and reducing tumor stroma, leading to improved antitumor efficacy and prolonged tumor growth inhibition in pancreatic cancer models.

Implementation Method 1

block copolymers with a polyacrylic acid backbone and PEG sidechains, combined with ε-caprolactone sidechains, forming micelles that encapsulate chemotherapeutic agents

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Data Source

PatentUS11026889B2Polymeric drug delivery systems for treatment of disease
Publication Date: 2021.06.08 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US11026889B2 patent drawing
  • US11026889B2 patent drawing
  • US11026889B2 patent drawing

AI summary

Provided are compositions and nanoparticle formulations that may be used, e.g., to deliver a therapeutic compound to a subject. In some embodiments, the nanoparticles may be used to deliver one or more chemotherapeutic agents to treat a cancer such, e.g., as a pancreatic ductal adenocarcinoma.